CG:600518 Kangmei Pharmaceutical Co., Ltd

Kangmei Pharmaceutical Co., Ltd is primarily engaged in the manufacture and sale of pharmaceutical products. The Companyís principal products are classified as Chinese medicines, including American ginseng, notoginseng powder, salvia powder, radix codonopsis pilosulae, maltiflower knotweed, angelica and lonicera flower, among others, as well as chemical drugs, including Clarithromycin Dispersible Tablets, Doxazosin Mesylate Tablets, Propiverine Hydrochloride Tablets and paracetamol and pseudoephedrine hydrochloride tablets, among others. The Company also involves in wholesaling and retailing of foodstuffs and other medical materials, such as birdís nest, ganoderma, sea horse, isinglass and forest frog, as well as the provision of real estate leasing and distribution services, among others.

3.19 CNY
As of 01/28/2022

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  China
Country of incorporation:  China
IPO date:  10/12/2006
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   42,284,896,256 CNY
Current dividend yield:   0.79%
Sedol:      6334350

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy